Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss
European Journal of Pharmaceutics and Biopharmaceutics · 2024-09 · 202 · 114393
DOI: 10.1016/j.ejpb.2024.114393 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-09. Verfasst von Zeinab Hajmohammadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Scienc…. Hauptthemen laut MEDLINE: Antioxidants, Hearing Loss, Sensorineural, Nanoparticles, Oxidative Stress. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 196 Literaturangaben.
Abstract (Originalsprache)
Sensorineural hearing loss (SNHL), often stemming from reactive oxygen species (ROS) generation due to various factors such as ototoxic drugs, acoustic trauma, and aging, remains a significant health concern. Oxidative stress-induced damage to the sensory cells of the inner ear, particularly the non-regenerating hair cells, is a critical pathologic mechanism leading to SNHL. Despite the proven efficacy of antioxidants in mitigating oxidative stress, their clinical application for otoprotection is hindered by the limitations of conventional drug delivery methods. This review highlights the challenges associated with systemic and intratympanic administration of antioxidants, including the blood-labyrinthine barrier, restricted permeability of the round window membrane, and inadequate blood flow to the inner ear. To overcome these hurdles, the application of nanoparticles as a delivery platform for antioxidants emerges as a promising solution. Nanocarriers facilitate indirect drug delivery to the cochlea through the round and oval window membrane, optimising drug absorption while reducing dosage, Eustachian tube clearance, and associated side effects. Furthermore, the development of nanoparticles carrying antioxidants tailored to the intracochlear environment holds immense potential. This literature research aimed to critically examine the root causes of SNHL and ROS overproduction in the inner ear, offering insights into the application of nanoparticle-based drug delivery systems for safeguarding sensorineural hair cells. By focusing on the intricate interplay between oxidative stress and hearing loss, this research aims to contribute to the advancement of innovative therapeutic strategies for the prevention of SNHL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Department of Tissue Engineering & Regenerative Medicin, Fa…
- ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Nanotechnology and Advanced Materials, Materials and Energy Research Centre (MERC), Tehran, Iran.
- Department of Biomedical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
- Skull Base Research Centre, The Five Senses Health Institute, School of Medicine, Iran University of Medical Science (IUMS), Tehran, Iran.
Zitieren
APA
Hajmohammadi, Z., Bagher, Z., Taghizadeh-Hesary, F., Khodadadi, M., Masror, N., Asghari, A., Valipour, B., & Seifalian, A. (2024). Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss. European Journal of Pharmaceutics and Biopharmaceutics, 202, 114393. https://doi.org/10.1016/j.ejpb.2024.114393
Vancouver
Hajmohammadi Z, Bagher Z, Taghizadeh-Hesary F, Khodadadi M, Masror N, Asghari A, et al. Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss. European Journal of Pharmaceutics and Biopharmaceutics. 2024;202:114393. doi:10.1016/j.ejpb.2024.114393
BibTeX
@article{Hajmohammadi2024,
author = {Hajmohammadi, Zeinab and Bagher, Zohreh and Taghizadeh-Hesary, Farzad and Khodadadi, Mahboobe and Masror, Niki and Asghari, Alimohamad and Valipour, Behnaz and Seifalian, Alexander},
title = {Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
volume = {202},
pages = {114393},
doi = {10.1016/j.ejpb.2024.114393}
}
EUVIMED